Lingfen Xu

623 total citations
24 papers, 424 citations indexed

About

Lingfen Xu is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Lingfen Xu has authored 24 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Lingfen Xu's work include Helicobacter pylori-related gastroenterology studies (6 papers), Inflammatory Bowel Disease (5 papers) and MicroRNA in disease regulation (4 papers). Lingfen Xu is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (6 papers), Inflammatory Bowel Disease (5 papers) and MicroRNA in disease regulation (4 papers). Lingfen Xu collaborates with scholars based in China, Belgium and Saudi Arabia. Lingfen Xu's co-authors include Mei Sun, Xu Teng, Jing Guo, Jing Guo, Hong‐Wei Sun, Ping Zhou, Jianhua Fu, Yvan Vandenplas, Yun Wang and Yang Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Biochemical and Biophysical Research Communications.

In The Last Decade

Lingfen Xu

22 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingfen Xu China 11 159 97 93 74 69 24 424
Dulce C. Macias-Ceja Spain 11 186 1.2× 109 1.1× 109 1.2× 35 0.5× 36 0.5× 19 469
Yuexin Yang China 10 259 1.6× 35 0.4× 98 1.1× 58 0.8× 25 0.4× 20 447
Navdha Mittal United States 8 256 1.6× 154 1.6× 122 1.3× 47 0.6× 43 0.6× 9 569
Rongbei Liu China 9 223 1.4× 42 0.4× 113 1.2× 21 0.3× 71 1.0× 19 439
Su Hyuk Ko South Korea 14 272 1.7× 148 1.5× 107 1.2× 66 0.9× 14 0.2× 24 563
Anastasios Angelou Greece 11 130 0.8× 119 1.2× 87 0.9× 35 0.5× 24 0.3× 28 446
Roman Inglin Switzerland 6 108 0.7× 246 2.5× 136 1.5× 40 0.5× 42 0.6× 13 538
Chin-Hee Song South Korea 12 208 1.3× 58 0.6× 43 0.5× 37 0.5× 19 0.3× 15 363

Countries citing papers authored by Lingfen Xu

Since Specialization
Citations

This map shows the geographic impact of Lingfen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfen Xu more than expected).

Fields of papers citing papers by Lingfen Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingfen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfen Xu. The network helps show where Lingfen Xu may publish in the future.

Co-authorship network of co-authors of Lingfen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingfen Xu. A scholar is included among the top collaborators of Lingfen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfen Xu. Lingfen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhihua, et al.. (2025). Machine learning differentiation of abdominal IgA vasculitis without purpura from appendicitis. Pediatric Research. 99(3). 964–969.
3.
Zhang, Kun, et al.. (2025). Bile acid-mediated gut-liver axis crosstalk: the role of nuclear receptor signaling in dynamic regulation of inflammatory networks. Frontiers in Immunology. 16. 1595486–1595486. 9 indexed citations
4.
Xu, Lingfen, et al.. (2024). Tarm1 may affect colitis by regulating macrophage M1 polarization in a mouse colitis model. Pediatric Research. 98(1). 286–293. 1 indexed citations
5.
Li, Shasha, et al.. (2024). Effects of multicomponent exercise on frailty status and physical function in frail older adults: A meta-analysis and systematic review. Experimental Gerontology. 197. 112604–112604. 7 indexed citations
7.
Xu, Lingfen, et al.. (2023). Case report: Diagnosis and treatment of DGAT1 deficiency-induced congenital diarrhea in two cases and literature review. Frontiers in Pediatrics. 11. 1253800–1253800. 2 indexed citations
8.
Xu, Lingfen, et al.. (2023). Macrophage polarization in inflammatory bowel disease. Cell Communication and Signaling. 21(1). 367–367. 85 indexed citations
9.
Xu, Lingfen, et al.. (2021). Protection by microRNA-7a-5p Antagomir Against Intestinal Mucosal Injury Related to the JNK Pathway in TNBS-Induced Experimental Colitis. The Turkish Journal of Gastroenterology. 32(5). 431–436. 9 indexed citations
10.
Xu, Lingfen, et al.. (2020). The JAK2 inhibitor AG490 regulates the Treg/Th17 balance and alleviates DSS‐induced intestinal damage in IBD rats. Clinical and Experimental Pharmacology and Physiology. 47(8). 1374–1381. 21 indexed citations
11.
Teng, Xu, Lu Liu, Lijuan Yang, et al.. (2020). Evaluation of inflammatory bowel disease activity in children using serum trefoil factor peptide. Pediatric Research. 88(5). 792–795. 7 indexed citations
12.
Guo, Jing, Lijuan Yang, Mei Sun, & Lingfen Xu. (2019). Inhibiting microRNA-7 Expression Exhibited a Protective Effect on Intestinal Mucosal Injury in TNBS-Induced Inflammatory Bowel Disease Animal Model. Inflammation. 42(6). 2267–2277. 13 indexed citations
13.
Guo, Jing, Lingfen Xu, Xu Teng, & Mei Sun. (2017). MicroRNA-7-5p regulates the proliferation and migration of intestinal epithelial cells by targeting trefoil factor 3 via inhibiting the phosphoinositide 3-kinase/Akt signalling pathway. International Journal of Molecular Medicine. 40(5). 1435–1443. 23 indexed citations
14.
Guo, Jing, Mei Sun, Xu Teng, & Lingfen Xu. (2017). MicroRNA-7-5p regulates the expression of TFF3 in inflammatory bowel disease. Molecular Medicine Reports. 16(2). 1200–1206. 17 indexed citations
15.
Xu, Lingfen, Yun Wang, Yang Wang, et al.. (2016). A double-blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I-745 in formula-fed preterm infants. Jornal de Pediatria. 92(3). 296–301. 34 indexed citations
17.
Xu, Lingfen, et al.. (2013). The protective effect of trefoil factor 3 on the intestinal tight junction barrier is mediated by toll-like receptor 2 via a PI3K/Akt dependent mechanism. Biochemical and Biophysical Research Communications. 440(1). 143–149. 57 indexed citations
18.
Xu, Lingfen, Xu Teng, Jing Guo, & Mei Sun. (2011). Protective Effect of Intestinal Trefoil Factor on Injury of Intestinal Epithelial Tight Junction Induced by Platelet Activating Factor. Inflammation. 35(1). 308–315. 42 indexed citations
19.
Xu, Lingfen, et al.. (2011). Disruption of the F-actin cytoskeleton and monolayer barrier integrity induced by PAF and the protective effect of ITF on intestinal epithelium. Archives of Pharmacal Research. 34(2). 245–251. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026